NCT04551963 2024-10-26Interaction Study of Zanubrutinib With Moderate and Strong CYP3A Inhibitors in Participants With B-Cell MalignanciesBeiGenePhase 1 Completed26 enrolled 20 charts
NCT02117648 2019-01-07A Study of LY2835219 in Participants With CancerEli Lilly and CompanyPhase 1 Completed26 enrolled 11 charts
NCT01454076 2017-11-01Pharmacokinetics Study of Oral IXAZOMIB in Participants With Advanced Nonhematologic Malignancies or LymphomaTakedaPhase 1 Completed112 enrolled 19 charts